Farmacosmo Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	58.85	63.7	72.07	66.43	58.37	44.44
Other Revenue	0.39	0.41	0.36	0.16	0.12	0.04
Revenue	59.23	64.1	72.44	66.59	58.5	44.48
Revenue Growth (YoY)	-13.10%	-11.51%	8.79%	13.83%	31.51%	82.96%
Cost of Revenue	59.31	63.1	72.04	66.42	56.67	43.08
Gross Profit	-0.08	1.01	0.39	0.16	1.83	1.4
Selling, General & Admin	0.35	0.36	0.53	0.17	0.13	0.11
Amortization of Goodwill & Intangibles	2.59	2.56	2.72	1.38	0.38	0.25
Other Operating Expenses	0.33	0.29	0.28	0.1	0.15	0.14
Operating Expenses	3.34	3.29	3.64	1.81	0.76	0.54
Operating Income	-3.42	-2.28	-3.24	-1.65	1.07	0.87
Interest Expense	-1.27	-1.2	-0.95	-0.55	-	-
Interest & Investment Income	0.03	0.38	0.01	-	-	-
Currency Exchange Gain (Loss)	0	-0	-0	-	-0	-0
Other Non Operating Income (Expenses)	-	0	0	0.04	-0.4	-0.34
Pretax Income	-4.65	-3.1	-4.18	-2.16	0.66	0.52
Income Tax Expense	0.11	-0.03	-0.25	-0.15	0.25	0.15
Earnings From Continuing Operations	-4.77	-3.07	-3.93	-2	0.41	0.37
Net Income to Company	-	-3.07	-3.93	-2	0.41	0.37
Minority Interest in Earnings	-0.07	0.1	0.7	0.67	-	-
Net Income	-4.83	-2.97	-3.23	-1.34	0.41	0.37
Net Income to Common	-4.83	-2.97	-3.23	-1.34	0.41	0.37
Net Income Growth	-	-	-	-	10.90%	178.23%
Shares Outstanding (Basic)	39	39	39	-	30	-
Shares Outstanding (Diluted)	39	39	39	-	30	-
EPS (Basic)	-0.12	-0.08	-0.08	-	0.01	-
EPS (Diluted)	-0.12	-0.08	-0.08	-	0.01	-
Free Cash Flow	-2.07	-2.18	-5.29	-	-0.43	1.71
Free Cash Flow Per Share	-0.05	-0.06	-0.14	-	-0.01	-
Dividend Per Share	-	-	-	-	0.010	-
Gross Margin	-0.13%	1.57%	0.54%	0.24%	3.12%	3.15%
Operating Margin	-5.77%	-3.56%	-4.48%	-2.47%	1.82%	1.95%
Profit Margin	-8.16%	-4.64%	-4.46%	-2.01%	0.71%	0.84%
Free Cash Flow Margin	-3.50%	-3.40%	-7.31%	-	-0.73%	3.84%
EBITDA	-1.72	-0.32	-0.42	-1.37	1.34	1.14
EBITDA Margin	-2.90%	-0.50%	-0.58%	-2.06%	2.29%	2.57%
D&A For EBITDA	1.7	1.96	2.83	0.28	0.28	0.28
EBIT	-3.42	-2.28	-3.24	-1.65	1.07	0.87
EBIT Margin	-5.77%	-3.56%	-4.48%	-2.47%	1.82%	1.95%
Effective Tax Rate	-	-	-	-	37.30%	28.66%
Revenue as Reported	59.39	64.26	72.61	66.64	58.5	44.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.